Menu Back to Joint-EFGCP-DIA-Better-Medicines-for-Children-Conference


This conference is a yearly event organised by the EFGCP Children Medicines Working Party in collaboration with DIA and Regulators to take stock of the progress achieved in the paediatric field after ten years of Paediatric Regulation

This year’s conference focuses on what could be done to optimise children’s access to new medicines.

“Access” can be broadly defined as:

  • Inclusion of paediatric patients into clinical trials
  • Health authority approval of a new medicine and
  • Children’s access to a medicine that has been approved by regulators.

Conference Features:

  • Keynotes by Francoise Grossetête, Member of the European Parliament, and Andrzej Rys, Director of Health Systems and Products, European Commission
  • Interactive breakout sessions for participants to actively engage in identifying innovative solutions to address access issues specific to paediatric subpopulations, such as adolescents, or neonates.
  • Q&A session with members of the EMA Paediatric committee (PDCO), moderated by Dr Dirk Mentzer (PDCO chair) will help understand PDCO specific activities and priorities, and address questions from the audience.
  • NEW! Poster Session where presenting authors of the winning posters will have the possibility to publish an abstract of their work in “Therapeutic Innovation & Regulatory Science” magazine.

Visit the EFGCP event page to learn more and to register to the event.

Learn More

Program Committee

  • Dimitrios  Athanasiou, MBA
    Dimitrios Athanasiou, MBA Patient Advocate
  • Christina  Bucci-Rechtweg, MD
    Christina Bucci-Rechtweg, MD Global Head, Pediatric and Maternal Health Policy, Drug Regulatory Affairs
    Novartis Pharmaceuticals Corporation, United States
  • Solange  Corriol-Rohou, DrMed, MD, PhD
    Solange Corriol-Rohou, DrMed, MD, PhD Senior Director, Global Regulatory Affairs & Policy, Europe
    Astrazeneca Research & Development, France
  • Martine  Dehlinger-Kremer, PhD
    Martine Dehlinger-Kremer, PhD Vice President, Pediatric Development
    Synteact, United States
  • Sabine  Fuerst Recktenwald, MD
    Sabine Fuerst Recktenwald, MD Global Development Team Leader
    F.HOFFMANN LA ROCHE LTD, Switzerland
  • Angelika  Joos, MPharm
    Angelika Joos, MPharm Executive Director, Global Regulatory Policy
    MSD (Europe) Inc., Belgium
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions